dr. kantoff on approaches for progressive prostate cancer following androgen blockade
Published 3 years ago • 130 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
0:48
dr. kantoff on evolving role of docetaxel in prostate cancer treatment
-
2:07
dr. kantoff on docetaxel plus androgen deprivation therapy in prostate cancer
-
3:50
considering adt’s role in advanced prostate cancer
-
1:27
dr. zhang discusses the impact of the stampede trial in prostate cancer
-
2:28
exploring androgen dependence in progressive prostate cancer
-
10:36
therapeutic options for advanced prostate cancer
-
8:28
metastatic prostate cancer: androgen receptor biology
-
0:52
prostate cancer treatment options
-
1:56:31
treatment across the prostate cancer continuum for primary care clinician
-
6:13
treatment options in post-docetaxel prostate cancer, part i
-
1:30
how far away are we from implementing ctc-based approaches in prostate cancer?
-
3:13
prostate cancer: treatment sequencing and choice
-
1:32
dr. hahn discusses abiraterone versus docetaxel in prostate cancer
-
0:41
how common is prostate cancer?
-
0:52
which treatment option is right for me?
-
2:22
how one fathers diagnosis accelerated prostate cancer research
-
9:23
hormone-sensitive metastatic prostate cancer
-
58:33
prostate cancer webinar 2021
-
0:55
dr. david crawford on sipuleucel-t in advanced prostate cancer